Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead
Antimicrobial Stewardship & Healthcare Epidemiology · 2025 · 5 (1)
DOI: 10.1017/ash.2025.10144 ↗Kurz gefasst
Editorial in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 09.12.2025. Verfasst von Radhika Arya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Quality, Safety & Health Equity, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Radhika Arya, Alex N Zimmet, Marisa Holubar
Zitieren
APA
Arya, R., Zimmet, A. N., Holubar, M., & Alegria, W. (2025). Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2025.10144
Vancouver
Arya R, Zimmet AN, Holubar M, Alegria W. Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Antimicrobial Stewardship & Healthcare Epidemiology. 2025;5(1). doi:10.1017/ash.2025.10144
BibTeX
@article{Arya2025,
author = {Arya, Radhika and Zimmet, Alex N and Holubar, Marisa and Alegria, William},
title = {Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2025},
volume = {5},
number = {1},
doi = {10.1017/ash.2025.10144}
}
EUVIMED